🤖 Search 5,000+ AI tools Ask our bot for help →

Discover the latest tools and trends in AI 🔮

Join 60,000+ subscribers including Amazon, Apple, Google, and Microsoft employees reading our free newsletter.

[email protected] Subscribe

Omniscient secures $50M Series C for expansion

Omniscient secures $50M Series C for expansion
Omniscient secures $50M Series C for expansion

Omniscient, based in Sydney, Australia, secured Series C funding of an undisclosed amount.

The funding round brought the company’s total to US$60M and included an undisclosed investor. The funds will be used for US market expansion and further product development.

Omniscient, led by CEO Stephen Scheeler, utilizes AI in connectomics to map brain networks through its Quicktome platform. The recent FDA-cleared fMRI tool marks a significant advancement.

Quicktome is already in use in over 100 US hospitals and clinics, positioning Omniscient as a leader in neurological tools.

Comments